CACNA1H and diabetes mellitus: Increased expression of Cav3.2 in primary afferent nociceptive fibers is causally linked to the development of peripheral painful neuropathy associated with nerve injury [18–20], antineoplastic drugs [21–23], inflammation [24,25], and diabetes [1,3].